Surgery Partners (SGRY) Form 4: Director disposition of 20,018 shares

Rhea-AI Filing Summary

Form 4 summary: Teresa DeLuca, identified as a director of Surgery Partners, Inc. (SGRY), reported a sale of 20,018 shares of the issuer's common stock on 08/11/2025 at a weighted average price of $22.74 per share. After the reported sale, the filing shows 45,173 shares beneficially owned. The sale was reported on a Form 4 and signed by an attorney-in-fact.

Insights

Financial Analyst

TL;DR: Routine insider sale by a director reducing direct holdings; no additional financial data provided to assess material impact.

The filing documents a straightforward disposition of 20,018 common shares by Teresa DeLuca at a weighted average price of $22.74, leaving 45,173 shares beneficially owned. This Form 4 records the mechanics of the transaction rather than operational or financial performance metrics. There is no disclosure here of the reason for the sale, any planned trading arrangement, or any change in company guidance or results. As such, the report is useful for ownership tracking but does not by itself indicate a material change to the companys fundamentals.

Corporate Governance Expert

TL;DR: Insider sale by a director is disclosed correctly; disclosure supplies required ownership and transaction detail but lacks explanatory context.

The Form 4 meets Section 16 reporting requirements by listing the directors disposition of 20,018 shares and the resulting beneficial ownership of 45,173 shares. The filing identifies the reporting person as a director and uses the correct transaction code for a sale. The document does not describe any hedging, 10b5-1 plan, or related-party arrangements, so governance observers will note compliance with reporting rules while recognizing the absence of contextual information that might clarify motives or timing.

Insider Trade Summary

Net Seller: 20,018 shares ($455,209)

Net Sell 1 txn

Insider DeLuca Teresa

Role Director

Sold 20,018 shs ($455K)

Type	Security	Shares	Price	Value
Sale	Common Stock	20,018	$22.74	$455K

Holdings After Transaction: Common Stock — 45,173 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeLuca Teresa

(Last) (First) (Middle)

C/O SURGERY PARTNERS, INC.

340 SEVEN SPRINGS WAY, SUITE 600

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Surgery Partners, Inc. [ SGRY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2025		S		20,018	D	$22.74(1)	45,173	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Jennifer Baldock, Attorney-in-Fact	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.